Building Effective Stem Cell-Based Models of Brain Disorders for Drug Discovery & Therapeutic Development

On the mission to introduce human biology early in drug discovery, NeuCyte builds in vitro disease models for neurological and neurodegenerative disorders through high quality SynFire® iPSC-derived neurons and broad assay capabilities. 
 
During this webinar, NeuCyte’s VP of BD and Operations, Ji Wu, PhD, shares how our unique technology platform has been applied to improving translatability in areas like epilepsy and autism drug screening, and neurotoxicity assessment of compounds. Find out how NeuCyte can enable your CNS drug discovery.